American injectables

Oct 10, 2025 . 2 Min Read

FDA’s New ANDA Pilot: A Win for U.S. Manufacturing

FDA’s ANDA Prioritization Pilot: What It Means for U.S. Generics and CDMOs

Read More

Digital Confidence: Building Trust in Sterile Manufacturing

The sterile injectable space is evolving quickly, and capacity and compliance alone are no longer en...

Read More
1 Min. Read

Pharma Tariffs Push for U.S. Production

What the New Pharma Tariff Means for CDMOs and Sterile Injectables The U.S. just announced a propose...

Read More
1 Min. Read

Bigger and Built to Deliver.

  In sterile injectable manufacturing, growth isn’t optional, it’s key.

Read More
1 Min. Read

American Injectables Announces Key Leadership Appointments to Drive Future Growth

American Injectables, a leading contract development and manufacturing organization (CDMO) specializ...

Read More
2 Min. Read

American Injectables Earns FDA Approval

BROOKSVILLE, FL (January 9, 2025) — American Injectables, a contract development and manufacturing o...

Read More
1 Min. Read

A Business-Minded Guide to Injectable Solutions and Market Trends

You don’t need a PhD in biochemistry to work in the pharmaceutical industry. However, understanding ...

Read More
3 Min. Read

Pharmaceutical Data Integrity: Protecting Your Branded Formulation

Imagine spending years and hundreds of thousands of dollars on a formulation, only to have it compro...

Read More
3 Min. Read

Special Considerations for Developing Parenteral Formulations

Compared to oral and transdermal medicine, parenteral formulations are potent and fast-acting. With ...

Read More
3 Min. Read

Strengthening the Pharmaceutical Supply Chain: It Starts With Formulation

The effects of supply chain issues are often most noticeable at the consumer level, manifesting as p...

Read More
3 Min. Read